Autolus Therapeutics Announces Collaboration With Bristol Myers Squibb For Use Of Autolus’ Safety Switch System
- Bristol Myers Squibb to receive access to Autolus’ RQR8 safety switch for use in cell therapy programs -
- Autolus to receive an upfront payment, with potential for near term option exercise fees and development